Public Profile

Amneal

Amneal Pharmaceuticals, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2002, the company has established itself as a leader in the development and manufacturing of generic and specialty pharmaceuticals. With a strong operational presence across North America and beyond, Amneal focuses on delivering high-quality, affordable medications that cater to a diverse range of therapeutic areas. The company’s core offerings include a wide array of generic drugs, specialty products, and over-the-counter medications, distinguished by their commitment to quality and innovation. Amneal has achieved significant milestones, including strategic partnerships and a robust pipeline of products, positioning itself as a trusted name in the market. With a dedication to improving patient access to essential medications, Amneal Pharmaceuticals continues to make a meaningful impact in the healthcare landscape.

DitchCarbon Score

How does Amneal's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Amneal's score of 25 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Amneal's reported carbon emissions

Amneal Pharmaceuticals, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the pharmaceutical industry is increasingly focusing on sustainability and reducing carbon footprints. Companies are encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As Amneal navigates this landscape, it may consider aligning with industry standards to enhance its climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Amneal's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Amneal is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Amneal is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Taro Pharmaceutical Industries Ltd.

IL
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Sandoz

CH
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Auro Medics Pharma Llc

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Sumitomo Pharma America, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Aurobindo Pharma USA, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers